CDW Corporation Stock Wall Street Sentiment and Market Outlook Fed Minutes Reveal Potential Rate Hikes as Iran War Risks Keep Inflation Elevated Microsoft and Anthropic in Talks for Custom AI Chip Deal Following 5 Billion Investment Anthropics Olah Urges AI Governance Outside Big Tech Warns of LargeScale Labor Displacement Microsoft and Anthropic in Talks for Custom AI Chip Deal Following 5 Billion Investment Home Depot Comparable Sales Match Lowes Signaling Potential Stock Performance Shift JXN Q1 2026 Earnings EPS Misses Estimates Amid Market Headwinds NGEN Q3 2025 Earnings NarrowerthanExpected Loss Drives Positive Market Response LIVE Q1 2026 Earnings Profitability Achieved Amidst Challenging Environment ICL Q1 2026 Earnings EPS Beats Estimates by 1458 Stock Slightly Down Kirby KEX Q1 2026 Earnings Strong EPS Beat Amid Modest Stock Decline CTMX Q1 2026 Earnings Narrower Loss Exceeds Expectations as Pipeline Advances Netskope Inc NTSK Gains 156 as Shares Push Toward Key Resistance LeonaBio Inc LONA Rises 145 as Shares Approach Key Resistance at 103 Fusemachines Inc FUSE Faces Renewed Pressure as Shares Approach Key Support at 132 Labcorp Holdings LH Holds Steady Near Resistance as Trading Volume Remains Subdued Post Holdings POST Holds Steady Near 9650 Testing Key Resistance Zone Geosphere Capitals Arvind Sanger Cautious Optimism on India as Earnings Revival Eyed Scienjoy Holding Corporation SJ Q1 2025 Earnings Net Loss Reported Amid Limited Disclosures Ocean Power Technologies OPTT Slides Slightly as Stock Hovers Near Key Support PTCT Q1 2026 Earnings Significant EPS Beat Highlights Cost Discipline Amid Pipeline Progress PBH Q1 2026 Earnings EPS Misses Estimates as Revenue Details Remain Unclear CLDI Q4 2025 Earnings Significant EPS Beat Despite No Revenue PENN Q1 2026 Earnings Steep EPS Miss Amid Operational Headwinds ATRA Q1 2026 Earnings Loss Narrows More Than Expected Amid Ongoing Pipeline Progress NMRK Q1 2026 Earnings EPS Surpasses Estimates by 18 Stock Unchanged Milestone Pharmaceuticals MIST Q1 2026 Earnings EPS Miss Deepens as ClinicalStage Biotech Navigates Development Path